BlackRock’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21B Buy
52,590,933
+129,018
+0.2% +$10.6M 0.07% 230
2025
Q4
$4.47B Sell
52,461,915
-1,832,258
-3% -$150M 0.08% 210
2025
Q3
$4.22B Sell
54,294,173
-1,353,059
-2% -$106M 0.07% 224
2025
Q2
$4.35B Buy
55,647,232
+935,639
+2% +$69.8M 0.08% 204
2025
Q1
$3.97B Buy
54,711,593
+191,273
+0.4% +$13.7M 0.08% 212
2024
Q4
$4.04B Sell
54,520,320
-64,846
-0.1% -$4.54M 0.08% 203
2024
Q3
$3.6B Buy
54,585,166
+3,609,674
+7% +$262M 0.08% 234
2024
Q2
$4.71B Sell
50,975,492
-1,444,106
-3% -$128M 0.11% 153
2024
Q1
$5.01B Buy
52,419,598
+246,821
+0.5% +$20.7M 0.12% 147
2023
Q4
$3.98B Buy
52,172,777
+797,331
+2% +$55.5M 0.1% 172
2023
Q3
$3.56B Buy
51,375,446
+565,575
+1% +$45.4M 0.1% 173
2023
Q2
$4.79B Sell
50,809,871
-964,483
-2% -$83.8M 0.13% 122
2023
Q1
$4.28B Sell
51,774,354
-1,287,454
-2% -$101M 0.13% 138
2022
Q4
$3.96B Buy
53,061,808
+659,372
+1% +$50.8M 0.12% 157
2022
Q3
$4.33B Sell
52,402,436
-3,338,252
-6% -$321M 0.15% 119
2022
Q2
$5.3B Sell
55,740,688
-1,285,734
-2% -$133M 0.17% 104
2022
Q1
$6.71B Sell
57,026,422
-14,561
-0% -$1.63M 0.18% 93
2021
Q4
$7.39B Buy
57,040,983
+4,007,132
+8% +$467M 0.19% 94
2021
Q3
$6B Buy
53,033,851
+172,681
+0.3% +$19.7M 0.17% 102
2021
Q2
$5.47B Sell
52,861,170
-4,280,280
-7% -$403M 0.15% 111
2021
Q1
$4.78B Sell
57,141,450
-1,455,110
-2% -$123M 0.14% 126
2020
Q4
$5.35B Sell
58,596,560
-440,949
-0.7% -$36.6M 0.17% 108
2020
Q3
$4.71B Sell
59,037,509
-406,466
-0.7% -$31.7M 0.18% 99
2020
Q2
$4.11B Buy
59,443,975
+3,464,782
+6% +$246M 0.17% 113
2020
Q1
$3.52B Buy
55,979,193
+1,376,796
+3% +$99.3M 0.17% 109
2019
Q4
$4.25B Buy
54,602,397
+4,944,819
+10% +$386M 0.16% 113
2019
Q3
$3.64B Buy
49,657,578
+117,015
+0.2% +$8.22M 0.15% 123
2019
Q2
$3.05B Sell
49,540,563
-2,093,931
-4% -$127M 0.13% 152
2019
Q1
$3.29B Buy
51,634,494
+2,340,237
+5% +$134M 0.15% 124
2018
Q4
$2.52B Buy
49,294,257
+3,384,246
+7% +$171M 0.13% 151
2018
Q3
$2.66B Sell
45,910,011
-544,572
-1% -$26.6M 0.12% 168
2018
Q2
$2.25B Sell
46,454,583
-505,983
-1% -$23.6M 0.1% 182
2018
Q1
$2.18B Buy
46,960,566
+728,355
+2% +$31.6M 0.1% 191
2017
Q4
$1.74B Buy
46,232,211
+995,688
+2% +$36.5M 0.08% 243
2017
Q3
$1.65B Buy
45,236,523
+2,907,981
+7% +$111M 0.08% 238
2017
Q2
$1.67B Buy
42,328,542
+317,457
+0.8% +$11.6M 0.09% 230
2017
Q1
$1.32B Buy
42,011,085
+40,172,454
+2,185% +$1.26B 0.07% 281
2016
Q4
$57.4M Buy
1,838,631
+106,878
+6% +$3.46M 0.08% 279
2016
Q3
$69.6M Sell
1,731,753
-108,432
-6% -$4.08M 0.1% 233
2016
Q2
$61.2M Buy
1,840,185
+363,579
+25% +$12.4M 0.09% 245
2016
Q1
$43.4M Sell
1,476,606
-373,995
-20% -$10.3M 0.07% 316
2015
Q4
$48.7M Sell
1,850,601
-1,352,949
-42% -$35.1M 0.07% 311
2015
Q3
$75.9M Buy
3,203,550
+48,048
+2% +$1.16M 0.12% 205
2015
Q2
$74.9M Sell
3,155,502
-183,258
-5% -$4.14M 0.11% 215
2015
Q1
$79.3M Buy
3,338,760
+1,051,974
+46% +$23.6M 0.11% 214
2014
Q4
$48.5M Buy
2,286,786
+383,586
+20% +$7.71M 0.07% 307
2014
Q3
$32.4M Buy
1,903,200
+32,058
+2% +$506K 0.05% 393
2014
Q2
$26.8M Sell
1,871,142
-79,014
-4% -$1.07M 0.04% 443
2014
Q1
$24.1M Sell
1,950,156
-814,356
-29% -$9.4M 0.04% 460
2013
Q4
$30.3M Buy
2,764,512
+821,112
+42% +$9.26M 0.05% 384
2013
Q3
$22.6M Buy
1,943,400
+542,502
+39% +$6.35M 0.04% 424
2013
Q2
$15.7M Buy
+1,400,898
New +$16.6M 0.03% 491

Other funds holding EW